Mode VC

David Moore

Senior Partner atArch Venture PartnersFirm active Sep 28Illinois
Arch Venture Partners websiteFirm profile

David Moore is a Senior Partner at ARCH Venture Partners, joining in 2026. He previously served as President of Novo Nordisk US and has over 25 years of biopharma experience.

What David can write

Writes checks of$25K to $30M+
Comes in atPre-seed, Seed, Series A, Series BCan lead the round
Ownership target7-10%At first check
Pitch pageSubmit on their siteThe firm asks founders to apply here.

Arch Venture Partners writes $25K to $30M+ checks, larger than 1% of firms in the atlas.

Bars: how many firms report each check band. Highlighted: Arch Venture Partners.

Career

  1. Johnson & Johnson · not stated
    not stated
  2. Roivant · CEO
    not stated
  3. Gurnet Point Capital · Investment Partner
    not stated
  4. Novo Nordisk US · President
    not stated
  5. ARCH Venture Partners · Senior Partner
    Now

Focus

biopharmalife scienceshealth care services

Education

Towson University, degree in biologyLehigh University, MBAThomas Jefferson University, graduate program in population health and health policy

Also at Arch Venture Partners

Paul Berns
Paul BernsManaging Director
Keith CrandellCo-Founder & Managing Director
Kristina BurowManaging Director
Mark McDonnellManaging Director
Robert NelsenCo-Founder & Managing Director
Steve GillisManaging Director
Brian Cuneo
Brian CuneoSenior Partner
Carol Suh
Carol SuhPartner

Partners like David

At firms with a similar stage, sector and check size.

Jim Vaughan
Jim VaughanManaging Principal & Co-Founder, VCapital
Ali Tamaseb
Ali TamasebGeneral Partner, DCVC
Jinlin WangPartner, Foothill Ventures
Arunas ChesonisManaging Partner, Safar Partners
Wally WangFounding Partner, SAV (Scale Asia Ventures)
Ann DeWitt
Ann DeWittGeneral Partner, The Engine

Alert me when Arch Venture Partners is active

One email when David's firm raises a fund, adds a partner or shows new activity.

Founders and investors at a Mode VC gathering

Send Mode VC your deck

Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.

Send your deck

Questions

Who is David Moore?

David Moore is a Senior Partner at ARCH Venture Partners, joining in 2026. He previously served as President of Novo Nordisk US and has over 25 years of biopharma experience.

How much does David Moore invest?

David Moore invests through Arch Venture Partners, which writes checks of $25K to $30M+ at pre-seed, seed, series a, series b.

How do I pitch David Moore?

A warm intro from a founder Arch Venture Partners backed works best.

What did David Moore do before Arch Venture Partners?

not stated at Johnson & Johnson; CEO at Roivant; Investment Partner at Gurnet Point Capital; President at Novo Nordisk US.

Last updated 2026-10-15. Is this you? Ask for a correction.